IVF devices market size to grow by USD 411.6M from 2023-28

The in vitro fertilization (IVF) devices market size is expected to grow by USD 411.62 million, accelerating at a CAGR of 7.67% during the forecast period, according to Technavio market analysis. Companies are implementing various strategies like forming partnerships, mergers, expanding into new areas, and launching new products to improve their market position. The report also offers detailed analyses of the market’s competitive landscape, featuring information on 15 leading companies including ASTEC CO. Ltd., Cook Group Inc., Cryotech, Esco Micro Pte. Ltd., FUJIFILM Corp., Genea Ltd., Gynotec BV, Hamilton Thorne Ltd., KITAZATO Corp., LabIVF Asia Pte Ltd., Merck and Co. Inc., NidaCon International AB, Nikon Corp., Progyny Inc., Rocket Medical Plc, The Cooper Companies Inc., Thermo Fisher Scientific Inc. and Vitrolife AB.

In vitro fertilization (IVF) devices market 2024 – 2028: Segmentation analysis
The market is segmented by Product (Culture media and reagents, Accessories and disposables, and Instruments), End-user (Fertility clinics, Hospitals, and Research centers), and Geography (North America, Europe, Asia, and Rest of World (ROW)).

The culture media and reagents segment is expected to experience substantial market share growth during the forecast period. These essential substances are integral to nurturing and cultivating embryos outside the human body within IVF laboratories. They create an environment that replicates conditions within the female reproductive tract, facilitating the development and maturation of embryos before they are chosen for transfer into the uterus.

In vitro fertilization (IVF) devices market 2024 – 2028: Geographical analysis
In North America, it is anticipated that the in vitro fertilization (IVF) devices market will make a substantial contribution to the global market’s growth, accounting for approximately 43% during the forecast period. There is a rising trend in infertility cases in North America, driven by factors such as delayed childbearing, lifestyle changes, and medical conditions. Consequently, there is a growing demand for fertility treatments, particularly IVF. North America is known for its well-developed healthcare infrastructure and high-quality medical care, which includes access to advanced IVF technologies and treatments. Additionally, with the aging population in North America, more individuals and couples are turning to fertility treatments to address age-related fertility challenges, further fueling the demand for IVF services and devices. Technavio